title: Belinostat approved for use in treating rare lymphoma.
authors: Cheryl A
authors: CA
authors: Thompson
mesh_terms: D017277:Drug Approval; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D006877:Hydroxamic Acids; D013449:Sulfonamides; C487081:belinostat